Silvia Millán Martín

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Recent exploitation of the avian immune system has highlighted its suitability for the generation of high-quality, high-affinity antibodies to a wide range of antigens for a number of therapeutic and biotechnological applications. The glycosylation profile of potential immunoglobulin therapeutics is species specific and is heavily influenced by the(More)
  • 1